4//SEC Filing
Ridloff Elena 4
Accession 0000950170-25-084893
CIK 0001815442other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:47 PM ET
Size
8.4 KB
Accession
0000950170-25-084893
Insider Transaction Report
Form 4
Ridloff Elena
Director
Transactions
- Sale
Common Stock
2025-06-11$50.00/sh−4,500$225,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-11−4,500→ 4,500 totalExercise: $20.29Exp: 2032-06-29→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2025-06-11$20.29/sh+4,500$91,305→ 4,500 total
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 25, 2024 adopted by the reporting person.
- [F2]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following the vesting commencement date of June 29, 2022, subject to the reporting person's continued service relationship through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001772518
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:47 PM ET
- Size
- 8.4 KB